| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 18 | 2018 | 293 | 3.250 |
Why?
|
| Thrombectomy | 7 | 2018 | 27 | 2.030 |
Why?
|
| Intracranial Aneurysm | 5 | 2016 | 30 | 1.930 |
Why?
|
| Endovascular Procedures | 10 | 2018 | 33 | 1.860 |
Why?
|
| Cerebral Angiography | 5 | 2016 | 29 | 1.650 |
Why?
|
| Brain Ischemia | 9 | 2018 | 71 | 1.600 |
Why?
|
| Embolization, Therapeutic | 5 | 2014 | 26 | 1.470 |
Why?
|
| Intracranial Hemorrhages | 4 | 2017 | 14 | 1.230 |
Why?
|
| Thrombolytic Therapy | 6 | 2014 | 56 | 1.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2016 | 6 | 1.090 |
Why?
|
| Arteriovenous Fistula | 2 | 2016 | 9 | 1.090 |
Why?
|
| Aneurysm, Ruptured | 2 | 2016 | 16 | 1.070 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2017 | 10 | 0.880 |
Why?
|
| Radial Artery | 1 | 2021 | 10 | 0.830 |
Why?
|
| Humans | 46 | 2021 | 29361 | 0.700 |
Why?
|
| Cerebrovascular Disorders | 3 | 2015 | 132 | 0.650 |
Why?
|
| Stents | 4 | 2018 | 76 | 0.630 |
Why?
|
| Female | 29 | 2021 | 16211 | 0.600 |
Why?
|
| Patient Transfer | 1 | 2017 | 20 | 0.600 |
Why?
|
| Middle Aged | 22 | 2019 | 9823 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2021 | 770 | 0.580 |
Why?
|
| Informed Consent | 1 | 2015 | 19 | 0.530 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 41 | 0.520 |
Why?
|
| Neurosurgery | 2 | 2015 | 49 | 0.520 |
Why?
|
| Self-Help Groups | 1 | 2014 | 5 | 0.520 |
Why?
|
| Mandible | 2 | 2018 | 15 | 0.510 |
Why?
|
| Retrospective Studies | 15 | 2019 | 3273 | 0.510 |
Why?
|
| Aged | 20 | 2019 | 9447 | 0.500 |
Why?
|
| Adult | 17 | 2021 | 8604 | 0.500 |
Why?
|
| Social Media | 1 | 2014 | 27 | 0.490 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 67 | 0.480 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 3 | 0.480 |
Why?
|
| Maxilla | 1 | 2013 | 2 | 0.480 |
Why?
|
| Male | 26 | 2019 | 15637 | 0.470 |
Why?
|
| Cerebral Arteries | 1 | 2013 | 30 | 0.470 |
Why?
|
| Connexin 43 | 1 | 2012 | 8 | 0.440 |
Why?
|
| Gap Junctions | 1 | 2012 | 13 | 0.440 |
Why?
|
| Neuralgia | 1 | 2012 | 16 | 0.430 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 47 | 0.410 |
Why?
|
| Aged, 80 and over | 13 | 2018 | 4851 | 0.410 |
Why?
|
| Spinal Cord | 1 | 2012 | 103 | 0.410 |
Why?
|
| Checklist | 1 | 2011 | 36 | 0.400 |
Why?
|
| Bone Transplantation | 1 | 2013 | 224 | 0.400 |
Why?
|
| Tibia | 1 | 2013 | 259 | 0.400 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 68 | 0.400 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 4 | 0.390 |
Why?
|
| Astrocytes | 1 | 2012 | 122 | 0.390 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 20 | 0.390 |
Why?
|
| Device Removal | 1 | 2010 | 85 | 0.370 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 521 | 0.360 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2009 | 3 | 0.350 |
Why?
|
| Connective Tissue Diseases | 1 | 2009 | 9 | 0.350 |
Why?
|
| Migraine Disorders | 1 | 2009 | 14 | 0.340 |
Why?
|
| Adolescent | 7 | 2018 | 2280 | 0.340 |
Why?
|
| Communicable Diseases | 1 | 2009 | 24 | 0.340 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 1829 | 0.340 |
Why?
|
| Heart Defects, Congenital | 1 | 2009 | 30 | 0.330 |
Why?
|
| Neuroradiography | 1 | 2008 | 3 | 0.320 |
Why?
|
| Radiology, Interventional | 1 | 2008 | 6 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 24 | 0.320 |
Why?
|
| Education, Medical, Graduate | 1 | 2008 | 79 | 0.300 |
Why?
|
| Prognosis | 5 | 2018 | 840 | 0.300 |
Why?
|
| Inflammation | 1 | 2009 | 345 | 0.290 |
Why?
|
| Neurology | 1 | 2008 | 101 | 0.290 |
Why?
|
| Young Adult | 7 | 2018 | 1935 | 0.280 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2015 | 42 | 0.280 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2016 | 30 | 0.270 |
Why?
|
| Adenoviridae | 1 | 2005 | 20 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 184 | 0.270 |
Why?
|
| Morbidity | 2 | 2016 | 63 | 0.270 |
Why?
|
| Nanostructures | 1 | 2005 | 12 | 0.270 |
Why?
|
| False Positive Reactions | 2 | 2017 | 33 | 0.270 |
Why?
|
| Genetic Vectors | 1 | 2005 | 60 | 0.260 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 42 | 0.260 |
Why?
|
| Treatment Outcome | 9 | 2018 | 3476 | 0.250 |
Why?
|
| Genetic Therapy | 1 | 2005 | 89 | 0.250 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 10 | 0.250 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2004 | 12 | 0.240 |
Why?
|
| Coronary Angiography | 2 | 2021 | 91 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 333 | 0.220 |
Why?
|
| Kidney Neoplasms | 2 | 2013 | 60 | 0.220 |
Why?
|
| Catheter Ablation | 2 | 2013 | 78 | 0.210 |
Why?
|
| Lung Diseases | 1 | 2021 | 46 | 0.190 |
Why?
|
| Animals | 6 | 2014 | 4577 | 0.180 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 3 | 0.170 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 11 | 0.170 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2019 | 23 | 0.170 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 324 | 0.170 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2018 | 7 | 0.170 |
Why?
|
| Pelvic Neoplasms | 1 | 2018 | 7 | 0.170 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 56 | 0.170 |
Why?
|
| Embolectomy | 2 | 2015 | 5 | 0.170 |
Why?
|
| Intraoperative Care | 1 | 2018 | 44 | 0.170 |
Why?
|
| Cheek | 1 | 2018 | 1 | 0.170 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2018 | 33 | 0.170 |
Why?
|
| Prognathism | 1 | 2018 | 2 | 0.170 |
Why?
|
| Taiwan | 2 | 2019 | 7 | 0.160 |
Why?
|
| Child | 3 | 2015 | 1345 | 0.160 |
Why?
|
| Renal Dialysis | 1 | 2019 | 113 | 0.160 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 172 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 340 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2015 | 190 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 206 | 0.150 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 6 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 24 | 0.140 |
Why?
|
| Subdural Effusion | 1 | 2015 | 7 | 0.140 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2015 | 8 | 0.140 |
Why?
|
| Research Report | 1 | 2015 | 7 | 0.140 |
Why?
|
| Neurologic Examination | 1 | 2016 | 146 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2014 | 304 | 0.130 |
Why?
|
| Extracellular Fluid | 1 | 2014 | 3 | 0.130 |
Why?
|
| Research Personnel | 1 | 2015 | 20 | 0.130 |
Why?
|
| Writing | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 18 | 0.130 |
Why?
|
| Posterior Cerebral Artery | 1 | 2014 | 1 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2015 | 33 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 52 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2014 | 4 | 0.130 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 7 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 1 | 2014 | 7 | 0.130 |
Why?
|
| Aneurysm | 1 | 2014 | 11 | 0.130 |
Why?
|
| Hearing Loss | 1 | 2014 | 11 | 0.120 |
Why?
|
| Hearing | 1 | 2014 | 22 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 43 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2016 | 330 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2014 | 47 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2013 | 13 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2014 | 81 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 124 | 0.120 |
Why?
|
| Neurofibrillary Tangles | 1 | 2014 | 181 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 17 | 0.120 |
Why?
|
| tau Proteins | 1 | 2014 | 202 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 150 | 0.120 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 8 | 0.120 |
Why?
|
| Psychometrics | 1 | 2014 | 262 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 66 | 0.120 |
Why?
|
| Patient Selection | 2 | 2015 | 232 | 0.120 |
Why?
|
| Mice | 3 | 2014 | 1620 | 0.110 |
Why?
|
| Pain Threshold | 1 | 2012 | 20 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 31 | 0.110 |
Why?
|
| Hospitalization | 1 | 2015 | 317 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2013 | 394 | 0.110 |
Why?
|
| Neoplasms | 1 | 2015 | 247 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 144 | 0.110 |
Why?
|
| Angioplasty | 2 | 2010 | 5 | 0.100 |
Why?
|
| Hyperalgesia | 1 | 2012 | 46 | 0.100 |
Why?
|
| Radiotherapy Dosage | 3 | 2018 | 113 | 0.100 |
Why?
|
| Ductus Arteriosus | 1 | 2011 | 1 | 0.100 |
Why?
|
| Fetal Diseases | 1 | 2011 | 6 | 0.100 |
Why?
|
| Heart Aneurysm | 1 | 2011 | 6 | 0.100 |
Why?
|
| Foramen Ovale, Patent | 1 | 2011 | 12 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2011 | 18 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 8 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 173 | 0.100 |
Why?
|
| Transportation of Patients | 1 | 2011 | 6 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 16 | 0.100 |
Why?
|
| Suction | 1 | 2011 | 41 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 43 | 0.100 |
Why?
|
| Chicago | 1 | 2013 | 865 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 145 | 0.090 |
Why?
|
| Assisted Circulation | 1 | 2010 | 4 | 0.090 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 965 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 21 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 19 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 462 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2021 | 604 | 0.090 |
Why?
|
| Logistic Models | 1 | 2010 | 407 | 0.090 |
Why?
|
| Radiography | 1 | 2011 | 678 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2009 | 24 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 1184 | 0.090 |
Why?
|
| Risk Factors | 1 | 2016 | 2446 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 726 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2010 | 638 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2008 | 3 | 0.080 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2008 | 7 | 0.080 |
Why?
|
| Intracranial Thrombosis | 1 | 2008 | 6 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2013 | 1812 | 0.080 |
Why?
|
| Infant | 2 | 2014 | 531 | 0.080 |
Why?
|
| Medicine | 1 | 2008 | 11 | 0.080 |
Why?
|
| Age Factors | 1 | 2010 | 845 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2014 | 641 | 0.080 |
Why?
|
| Specialization | 1 | 2008 | 17 | 0.080 |
Why?
|
| Teaching | 1 | 2008 | 62 | 0.080 |
Why?
|
| Education, Medical | 1 | 2008 | 49 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2008 | 290 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 349 | 0.070 |
Why?
|
| Convection | 1 | 2005 | 1 | 0.070 |
Why?
|
| Osmosis | 1 | 2005 | 6 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 44 | 0.070 |
Why?
|
| Aortography | 1 | 2004 | 10 | 0.060 |
Why?
|
| Trauma Centers | 1 | 2004 | 7 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 453 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2013 | 21 | 0.060 |
Why?
|
| Rats | 1 | 2005 | 858 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 2 | 2013 | 59 | 0.060 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2002 | 4 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 42 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 154 | 0.050 |
Why?
|
| Pregnancy | 1 | 2021 | 404 | 0.040 |
Why?
|
| Malocclusion, Angle Class III | 1 | 2018 | 1 | 0.040 |
Why?
|
| Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.040 |
Why?
|
| Cephalometry | 1 | 2018 | 3 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 118 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2017 | 39 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 32 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 161 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 364 | 0.040 |
Why?
|
| Osteotomy | 1 | 2018 | 163 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 152 | 0.040 |
Why?
|
| Reperfusion | 1 | 2015 | 7 | 0.030 |
Why?
|
| Brain | 1 | 2005 | 1687 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 327 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 1618 | 0.030 |
Why?
|
| Aquaporin 4 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 75 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2014 | 13 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2014 | 55 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 117 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 114 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 49 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 324 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 340 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 67 | 0.030 |
Why?
|
| Iohexol | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 432 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 24 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 234 | 0.030 |
Why?
|
| Contrast Media | 1 | 2013 | 125 | 0.030 |
Why?
|
| Comorbidity | 1 | 2013 | 497 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 96 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 9 | 0.020 |
Why?
|
| Registries | 1 | 2011 | 189 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 54 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 226 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 226 | 0.020 |
Why?
|
| United States | 1 | 2015 | 2332 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cyclin D | 1 | 2008 | 1 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 3 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 6 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 17 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 10 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 24 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 108 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 251 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 202 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 174 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 957 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 1939 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 1220 | 0.010 |
Why?
|